Your account is not claimed yet. You can sign up with ORCID to claim your account.

Silvia Chaves (Sílvia Chaves)

Scopus Author ID ResearcherID Ciência ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 14

Top Venues

Molecules (Basel, Switzerland)

Dalton transactions (Cambridge, England : 2003)

Journal of enzyme inhibition and medicinal chemistry

International journal of molecular sciences

Universidade de Lisboa Instituto Superior Técnico

Universidade Técnica de Lisboa Instituto Superior Técnico (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidade de Lisboa Instituto Superior Técnico Jul 29o 1998

Portugal

Professora Auxiliar :: Departamento de Engenharia Química

Education History

Universidade Técnica de Lisboa Instituto Superior Técnico

Portugal

PHD :: Engenharia Química

Publications

David Vicente-Zurdo, Leonardo Brunetti, Luca Piemontese, Beatriz F S Guedes, Sandra Morais Cardoso, Daniel Chavarria, Fernanda Borges, Yolanda Madrid, Silvia Chaves, Maria Amélia Santos
Rivastigmine-Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases. International journal of molecular sciences 24 (9) (2023)
David Vicente-Zurdo, Leonardo Brunetti, Luca Piemontese, Beatriz F S Guedes, Sandra Morais Cardoso, Daniel Chavarria, Fernanda Borges, Yolanda Madrid, Silvia Chaves, Maria Amélia Santos
Rivastigmine-Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases. International journal of molecular sciences 24 (9) (2023)
Silvia Chaves, Karolina Gwizdała, Karam Chand, Lurdes Gano, Agnès Pallier, Éva Tóth, Maria Amélia Santos
Gd III and Ga III complexes with a new tris-3,4-HOPO ligand as new imaging probes: complex stability, magnetic properties and biodistribution. Dalton transactions (Cambridge, England : 2003) 51 (16) (2022)
Alessia Carocci, Alexia Barbarossa, Rosalba Leuci, Antonio Carrieri, Leonardo Brunetti, Antonio Laghezza, Marco Catto, Francesco Limongelli, Silvia Chaves, Paolo Tortorella, Cosimo Damiano Altomare, Maria Amélia Santos, Fulvio Loiodice, Luca Piemontese
Novel Phenothiazine/Donepezil-like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer's Disease. Antioxidants (Basel, Switzerland) 11 (9) (2022)
David Vicente-Zurdo, Noelia Rosales-Conrado, María Eugenia León-González, Leonardo Brunetti, Luca Piemontese, A Raquel Pereira-Santos, Sandra Morais Cardoso, Yolanda Madrid, Silvia Chaves, Maria Amélia Santos
Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer's Disease. Biomedicines 10 (7) (2022)
Maria Amélia Santos, Anna Irto, Péter Buglyó, Silvia Chaves
Hydroxypyridinone-Based Metal Chelators towards Ecotoxicity: Remediation and Biological Mechanisms. Molecules (Basel, Switzerland) 27 (6) (2022)
Beatrice Bargagna, Lidia Ciccone, Susanna Nencetti, Maria Amélia Santos, Silvia Chaves, Caterina Camodeca, Elisabetta Orlandini
Multifunctional Small Molecules as Potential Anti-Alzheimer's Disease Agents. Molecules (Basel, Switzerland) 26 (19) (2021)
Fausto Queda, Sonia Calò, Karolina Gwizdala, João D Magalhães, Sandra M Cardoso, Silvia Chaves, Luca Piemontese, Maria Amélia Santos
Novel Donepezil-Arylsulfonamide Hybrids as Multitarget-Directed Ligands for Potential Treatment of Alzheimer's Disease. Molecules (Basel, Switzerland) 26 (6) (2021)
Silvia Chaves, Simonetta Resta, Federica Rinaldo, Marina Costa, Romane Josselin, Karolina Gwizdala, Luca Piemontese, Alejandro Presa Soto, A Raquel Pereira-Santos, Sandra M Cardoso, Maria Amélia Santos
Design, Synthesis, and In Vitro Evaluation of Hydroxybenzimidazole-Donepezil Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease. Molecules (Basel, Switzerland) 25 (4) (2020)
Valeria Marina Nurchi, Rosita Cappai, Karam Chand, Silvia Chaves, Lurdes Gano, Guido Crisponi, Massimiliano Peana, Maria Antonietta Zoroddu, Maria Amélia Santos
New strong extrafunctionalizable tris(3,4-HP) and bis(3,4-HP) metal sequestering agents: synthesis, solution and in vivo metal chelation. Dalton transactions (Cambridge, England : 2003) 48 (43) (2019)
Rajeshwari Rajeshwari, Karam Chand, Emanuel Candeias, Sandra Morais Cardoso, Silvia Chaves, Maria Amélia Santos
New Multitarget Hybrids Bearing Tacrine and Phenylbenzothiazole Motifs as Potential Drug Candidates for Alzheimer's Disease. Molecules (Basel, Switzerland) 24 (3) (2019)
Gaia Fancellu, Karam Chand, Daniel Tomás, Elisabetta Orlandini, Luca Piemontese, Diana F Silva, Sandra Morais Cardoso, Silvia Chaves, Maria Amélia Santos
Novel tacrine-benzofuran hybrids as potential multi-target drug candidates for the treatment of Alzheimer's Disease. Journal of enzyme inhibition and medicinal chemistry 35 (1) (2019)
Karam Chand, Rajeshwari Rajeshwari, Emanuel Candeias, Sandra Morais Cardoso, Silvia Chaves, Maria Amélia Santos
Tacrine-deferiprone hybrids as multi-target-directed metal chelators against Alzheimer's disease: a two-in-one drug. Metallomics : integrated biometal science 10 (10) (2018)
Luca Piemontese, Daniel Tomás, Asha Hiremathad, Alejandro Presa Soto, Emanuel Candeias, Sandra Morais Cardoso, Silvia Chaves, Maria Amélia Santos
Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's drug candidates. Journal of enzyme inhibition and medicinal chemistry 33 (1) (2018)

Silvia Chaves.css-eqlu8i{font-size:small;padding-left:4px;} (Sílvia Chaves)

Publication Activity (10 Years)

Top Topics

Top Venues

Silvia Chaves (Sílvia Chaves)